APA (7th ed.) Citation

Mukhophadyay, A., Plummer, E. R., Elattar, A., San, S., Uzir, B. F., Quinn, J. E., . . . McCluggage, W. G. (2012). Clinicopathological features of homologous recombination deficient epithelial ovarian cancers: Sensitivity to PARP inhibitors, platinum and survival. American Association of Cancer Research.

Chicago Style (17th ed.) Citation

Mukhophadyay, Asima, et al. Clinicopathological Features of Homologous Recombination Deficient Epithelial Ovarian Cancers: Sensitivity to PARP Inhibitors, Platinum and Survival. American Association of Cancer Research, 2012.

MLA (8th ed.) Citation

Mukhophadyay, Asima, et al. Clinicopathological Features of Homologous Recombination Deficient Epithelial Ovarian Cancers: Sensitivity to PARP Inhibitors, Platinum and Survival. American Association of Cancer Research, 2012.